Reuters logo
BRIEF-Active Biotech ‍provides updated information about company's financial situation​
December 7, 2017 / 6:28 PM / 6 days ago

BRIEF-Active Biotech ‍provides updated information about company's financial situation​

Dec 7 (Reuters) - Active Biotech Ab:

* ‍PROVIDES UPDATED INFORMATION ABOUT COMPANY‘S FINANCIAL SITUATION​

* ‍BOARD HAS DECIDED TO SELL COMPANY‘S PROPERTY IN LUND AS A POSSIBLE WAY OF GENERATING ADDITIONAL LIQUIDITY FOR COMPANY​

* ‍SALES PROCESS INITIATED BY BOARD REGARDING COMPANY‘S PROPERTY IN LUND IS ONGOING BUT HAS NOT YET LED TO COMPLETION​

* ‍CURRENTLY HAS LIQUIDITY DEEMED NECESSARY TO FINANCE OPERATIONS UNTIL END OF Q2 OF 2018​

* ‍LOAN DEBT AMOUNTED TO SEK 210.8 MILLION ON SEPTEMBER 30, 2017​

* ACTIVE BIOTECH - UNLESS A SALE OF PROPERTY OR ANOTHER SOLUTION IS ACHIEVED, CO WILL LACK FUNDING TO ENSURE BUSINESS COMING TWELVE-MONTH PERIOD​

* ACTIVE BIOTECH - ‍ARPEGGIO STUDY RESULTS HAVE A DECISIVE NEGATIVE IMPACT ON CONTINUED DEVELOPMENT OF LAQUINIMOD IN PPMS Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below